| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59651-933-60 | 59651-933 | HUMAN PRESCRIPTION DRUG | everolimus | everolimus | TABLET | ORAL | 20260225 | N/A | ANDA | ANDA219533 | Aurobindo Pharma Limited | EVEROLIMUS | .75 mg/1 | 60 TABLET in 1 BOTTLE (59651-933-60) |
| 59651-934-60 | 59651-934 | HUMAN PRESCRIPTION DRUG | everolimus | everolimus | TABLET | ORAL | 20260225 | N/A | ANDA | ANDA219533 | Aurobindo Pharma Limited | EVEROLIMUS | 1 mg/1 | 60 TABLET in 1 BOTTLE (59651-934-60) |
| 59651-932-60 | 59651-932 | HUMAN PRESCRIPTION DRUG | everolimus | everolimus | TABLET | ORAL | 20260225 | N/A | ANDA | ANDA219533 | Aurobindo Pharma Limited | EVEROLIMUS | .5 mg/1 | 60 TABLET in 1 BOTTLE (59651-932-60) |
| 59651-931-60 | 59651-931 | HUMAN PRESCRIPTION DRUG | everolimus | everolimus | TABLET | ORAL | 20260225 | N/A | ANDA | ANDA219533 | Aurobindo Pharma Limited | EVEROLIMUS | .25 mg/1 | 60 TABLET in 1 BOTTLE (59651-931-60) |